NRXCF: AI 评分 56/100 — AI 分析 (4月 2026)

NeutriSci International Inc. develops and distributes nutraceutical products, including its flagship neuenergy tablet, across multiple continents. The company operates through retail and online channels, focusing on delivering enhanced focus and mental clarity.

Key Facts: AI Score: 56/100 Sector: Healthcare

公司概况

概要：

NeutriSci International Inc. operates in the nutraceuticals market, developing and distributing products like neuenergy across North America, Europe, and Asia. With a focus on energy and mental clarity, the company utilizes retail and online channels, facing competition in a fragmented and evolving market landscape.

NRXCF是做什么的？

NeutriSci International Inc., established in 2009 and headquartered in Vancouver, Canada, is a nutraceutical company engaged in the development, marketing, and distribution of health and wellness products. The company's flagship product, neuenergy, is an energy tablet designed to enhance focus and mental clarity. NeutriSci distributes its products through a network of retail and online channels, targeting consumers in Canada, the United States, Europe, Asia, and South America. The company has established partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid to expand its market reach and product offerings. NeutriSci operates in the competitive nutraceuticals market, which includes a wide range of dietary supplements and functional foods. The company aims to differentiate itself through innovative product formulations and effective distribution strategies. However, the company's negative gross and profit margins indicate potential challenges in achieving profitability and sustainable growth.

NRXCF的投资论点是什么？

Investing in NeutriSci International Inc. presents a high-risk, high-reward scenario. The company's negative gross margin of -9.5% and profit margin of -168.4% raise concerns about its financial sustainability. The company's success hinges on its ability to achieve significant revenue growth and improve its cost structure. Potential catalysts include successful expansion into new markets and the launch of additional nutraceutical products. However, the company's reliance on partnerships and the competitive nature of the nutraceuticals market pose significant risks. The negative beta of -0.83 suggests that the stock moves inversely to the market, which could provide some downside protection during market downturns, but also limit upside potential during bull markets. Investors should closely monitor the company's financial performance and market execution to assess its long-term viability.

NRXCF在哪个行业运营？

NeutriSci International Inc. operates within the global nutraceuticals market, which is characterized by increasing consumer interest in health and wellness products. The market includes dietary supplements, functional foods, and beverages. Competition is intense, with numerous players ranging from large multinational corporations to smaller, specialized companies. NeutriSci's success depends on its ability to differentiate its products, establish strong distribution channels, and effectively market its offerings. The company faces competition from established brands and emerging players, requiring continuous innovation and adaptation to changing consumer preferences.

Drug Manufacturers - Specialty & Generic

Healthcare

NRXCF有哪些增长机遇？

Expansion into New Geographies: NeutriSci has the opportunity to expand its distribution network into new geographic markets, particularly in Asia and South America, where demand for nutraceutical products is growing. By establishing partnerships with local distributors and tailoring its product offerings to meet regional preferences, NeutriSci can tap into new revenue streams and diversify its customer base. This expansion could increase revenue by an estimated 20% within the next three years.
Product Line Diversification: NeutriSci can expand its product line beyond neuenergy to include other nutraceutical products targeting different health and wellness needs. By developing and launching new products in categories such as immune support, digestive health, and sleep enhancement, NeutriSci can attract a broader range of customers and increase its market share. This diversification could lead to a 15% increase in revenue within the next two years.
Strategic Partnerships: NeutriSci can leverage strategic partnerships with other companies in the health and wellness industry to expand its reach and access new markets. By collaborating with complementary businesses, such as fitness centers, health food stores, and online retailers, NeutriSci can increase its brand awareness and distribution capabilities. These partnerships could contribute to a 10% increase in revenue within the next year.
Online Sales Growth: NeutriSci can focus on growing its online sales channels through e-commerce platforms and digital marketing initiatives. By investing in search engine optimization (SEO), social media marketing, and targeted advertising, NeutriSci can reach a wider audience and drive online sales. This strategy could result in a 25% increase in online revenue within the next two years.
Development of Innovative Formulations: NeutriSci can invest in research and development to create innovative nutraceutical formulations that address specific health concerns and provide unique benefits to consumers. By developing proprietary ingredients and delivery systems, NeutriSci can differentiate its products from competitors and attract health-conscious consumers. This innovation could lead to a 20% increase in revenue within the next three years.

Market Cap of $0.00B indicates a micro-cap company with limited resources and higher volatility.
P/E Ratio of -1.08 suggests the company is currently unprofitable, making traditional valuation difficult.
Profit Margin of -168.4% highlights significant challenges in achieving profitability and managing expenses.
Gross Margin of -9.5% indicates that the cost of goods sold exceeds revenue, raising concerns about pricing and production efficiency.
Beta of -0.83 suggests the stock has a negative correlation with the market, potentially offering some downside protection during market downturns.

NRXCF提供哪些产品和服务？

Develops nutraceutical products.
Markets nutraceutical products.
Distributes nutraceutical products.
Offers neuenergy, an energy tablet for focus and mental clarity.
Sells products through retail channels.
Sells products through online channels.

NRXCF如何赚钱？

Develops and manufactures nutraceutical products.
Distributes products through retail and online channels.
Generates revenue through product sales.
Partners with other companies for distribution and product development.

Individuals seeking enhanced focus and mental clarity.
Consumers interested in health and wellness products.
Retailers selling nutraceutical products.
Online consumers purchasing health supplements.

Proprietary formulations for neuenergy.
Established distribution network in multiple countries.
Partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid.
Brand recognition in the energy supplement market.

什么因素可能推动NRXCF股价上涨？

Upcoming: Potential expansion into new geographic markets, such as Asia and South America, by the end of 2026.
Upcoming: Launch of new nutraceutical products targeting different health and wellness needs in Q4 2026.
Ongoing: Strategic partnerships with complementary businesses to expand reach and access new markets.
Ongoing: Increased online sales through e-commerce platforms and digital marketing initiatives.
Ongoing: Development of innovative nutraceutical formulations with proprietary ingredients.

NRXCF的主要风险是什么？

Ongoing: Intense competition in the nutraceuticals market from established brands and emerging players.
Potential: Changing consumer preferences and regulatory requirements affecting product demand and compliance.
Potential: Supply chain disruptions impacting the availability and cost of raw materials.
Potential: Economic downturn affecting consumer spending on discretionary items like nutraceuticals.
Ongoing: The company's negative gross and profit margins raise concerns about its financial sustainability.

NRXCF的核心优势是什么？

Established distribution network in multiple countries.
Proprietary formulation for neuenergy.
Partnerships with other companies in the health and wellness industry.
Focus on a growing market segment (energy and mental clarity).

NRXCF的劣势是什么？

Negative gross and profit margins.
Limited financial resources.
Dependence on partnerships for distribution.
Small market capitalization.

NRXCF有哪些机遇？

Expansion into new geographic markets.
Product line diversification.
Increased online sales through e-commerce platforms.
Development of innovative nutraceutical formulations.

NRXCF面临哪些威胁？

Intense competition in the nutraceuticals market.
Changing consumer preferences and regulatory requirements.
Potential supply chain disruptions.
Economic downturn affecting consumer spending on discretionary items.

NRXCF的竞争对手是谁？

Elixinol Wellness Ltd — Focuses on hemp-derived CBD products. — (ELLXF)
Indiva Limited — Produces cannabis products. — (IDCN)
Microsys International Corp. — Unknown differentiation based on available data. — (MSMY)
New Pacific Healthcare Corp. — Unknown differentiation based on available data. — (NPHC)
PharmaChem Technologies (Cayman) Ltd. — Focuses on generic pharmaceutical products. — (PHCG)

Key Metrics

MoonshotScore: 56/100

Company Profile

CEO: Glen Rehman
Headquarters: Vancouver, CA
Founded: 2016

AI Insight

AI analysis pending for NRXCF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does NeutriSci International Inc. do?

NeutriSci International Inc. is a nutraceutical company that develops, markets, and distributes health and wellness products. Its primary offering is neuenergy, an energy tablet designed to enhance focus and mental clarity. The company operates through a distribution network of retail and online channels, targeting consumers in Canada, the United States, Europe, Asia, and South America. NeutriSci also forms partnerships with other companies, such as LaSanta Botanicals and Nutritional High, to expand its market reach and product offerings within the competitive nutraceuticals industry.

What do analysts say about NRXCF stock?

Currently, there is no readily available analyst coverage for NRXCF stock due to its OTC Other listing and small market capitalization. This lack of analyst coverage makes it difficult to obtain consensus estimates or valuation targets. Investors should rely on their own independent research and due diligence to assess the company's prospects and risks. Key metrics to consider include revenue growth, gross margin, profitability, and cash flow. The absence of analyst opinions adds to the risk profile of this investment.

What are the main risks for NRXCF?

The main risks for NeutriSci International Inc. include intense competition in the nutraceuticals market, changing consumer preferences, and regulatory requirements. The company's negative gross and profit margins raise concerns about its financial sustainability. As an OTC-listed company, NRXCF faces liquidity risks and limited financial disclosure. Dependence on partnerships for distribution and potential supply chain disruptions also pose challenges. Investors should carefully consider these risks before investing in NRXCF.